Frontier Capital Management’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $52.6M | Sell |
|
|||||
|
2024
Q1 | $55.9M | Sell |
|
|||||
|
2023
Q4 | $70.3M | Buy |
|
|||||
|
2023
Q3 | $55.2M | Buy |
|
|||||
|
2023
Q2 | $67.5M | Buy |
|
|||||
|
2023
Q1 | $65.5M | Buy |
|
|||||
|
2022
Q4 | $41M | Sell |
|
|||||
|
2022
Q3 | $60.4M | Buy |
|
|||||
|
2022
Q2 | $62M | Buy |
|
|||||
|
2022
Q1 | $80.5M | Buy |
|
|||||
|
2021
Q4 | $56M | Buy |
|
|||||
|
2021
Q3 | $44.5M | Sell |
|
|||||
|
2021
Q2 | $49.3M | Sell |
|
|||||
|
2021
Q1 | $72.8M | Buy |
|
|||||
|
2020
Q4 | $61.8M | Sell |
|
|||||
|
2020
Q3 | $65.2M | Sell |
|
|||||
|
2020
Q2 | $58M | Buy |
|
|||||
|
2020
Q1 | $36.2M | Sell |
|
|||||
|
2019
Q4 | $61.1M | Sell |
|
|||||
|
2019
Q3 | $63.9M | Buy |
|
|||||
|
2019
Q2 | $70.2M | Buy |
|
|||||
|
2019
Q1 | $52.5M | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $5.91M | Sell |
|
|||||
|
2017
Q1 | $5.79M | Buy |
|
|||||
|
2016
Q4 | $2.54M | Sell |
|
|||||
|
2016
Q3 | $2.87M | Sell |
|
|||||
|
2016
Q2 | $3.45M | Sell |
|
|||||
|
2016
Q1 | $8.77M | Sell |
|
|||||
|
2015
Q4 | $14.6M | Buy |
|